2023
DOI: 10.1016/j.jtha.2023.07.005
|View full text |Cite
|
Sign up to set email alerts
|

Cancer-associated fibroblasts promote venous thrombosis through podoplanin/CLEC-2 interaction in podoplanin-negative lung cancer mouse model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 48 publications
0
5
0
Order By: Relevance
“…The results showed that HSP47 is low in tumor cells of the primary tumors, although some non-cancer cells show high levels of HSP47, especially in cancer-associated fibroblasts (CAFs) ( Figures S1 D and S1F), which is consistent with previous reports. 15 , 16 However, the level of HSP47 is significantly upregulated in tumor cells in BrMs compared to the primary tumors ( Figures S1 E and S1G). Importantly, tumor cell is the most abundant cell type expressing HSP47 in BrMs.…”
Section: Resultsmentioning
confidence: 96%
“…The results showed that HSP47 is low in tumor cells of the primary tumors, although some non-cancer cells show high levels of HSP47, especially in cancer-associated fibroblasts (CAFs) ( Figures S1 D and S1F), which is consistent with previous reports. 15 , 16 However, the level of HSP47 is significantly upregulated in tumor cells in BrMs compared to the primary tumors ( Figures S1 E and S1G). Importantly, tumor cell is the most abundant cell type expressing HSP47 in BrMs.…”
Section: Resultsmentioning
confidence: 96%
“…Podoplanin is a well-known CAF marker similar to FAP [22]. Using a mouse model, Shirai et al [23] reported that extracellular vesicles derived from CAFs promote venous thrombus formation via podoplanin-dependent platelet aggregation. In the present study, podoplanin-positive cells were not observed in the aspirated thrombi.…”
Section: Discussionmentioning
confidence: 99%
“…Acting as a tumor suppressor gene by repressing the expression of vasohibin-1 (VASH1), EZH2, in turn, stimulated the proliferation of ECs. Conversely, inhibition of the VEGF/EZH2 axis led to upregulation of VASH1, which decreased tumor-associated angiogenesis [96] .…”
Section: Caf Interaction With Vascular Structuresmentioning
confidence: 99%